Dr. Lal PathLabs gets nod to acquire 70% stake in DLPLB

07 Aug 2017 Evaluate

Dr. Lal PathLabs has received an approval to acquire to 70 per cent stake in Dr. Lal Path Labs Bangladesh (DLPLB) from its existing shareholders, with the objective of strengthening its presence in Bangladesh. Prior to the company’s investment, DLPLB shall be acquiring the running diagnostics business of a sole-proprietorship firm in Dhaka, Bangladesh.

The Board of Directors of the Company at their meeting held on August 07, 2017, has given the approval for the same.

Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

Dr. Lal Pathlabs Share Price

2996.60 43.25 (1.46%)
23-Dec-2024 11:47 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7322.90
Max Healthcare Inst 1157.00
Narayana Hrudayalay 1306.00
Aster DM Healthcare 505.30
Global Health 1102.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.